Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Artesunate in Stage II/III Colorectal Cancer
NCT07095309Phase 2Not yet recruiting
- Sponsor
- Metanoic Health
- Start
- Aug 2025
- Primary completion
- Aug 2032
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of artesunate in colorectal cancer (CRC), sponsored by Metanoic Health. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
artesunate
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT07095309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07095309.